PETX Market Cap History



Below is a table of the PETX market cap history going back to 8/8/2013:

Date PETX Market Cap
8/8/2013209.31M
11/8/2013503.21M
3/10/2014590.13M
5/7/2014349.54M
8/8/2014325.40M
11/8/2014387.31M
3/9/2015681.80M
5/4/2015462.20M
8/3/2015607.69M
11/2/2015275.14M
3/10/2016135.76M
5/2/2016217.39M
8/1/2016265.62M
10/31/2016300.06M
3/9/2017253.32M
5/1/2017237.99M
8/1/2017287.68M
10/30/2017249.83M
3/9/2018195.34M
4/30/2018241.25M
7/30/2018211.66M
10/29/2018291.26M
3/8/2019183.16M
5/3/2019232.60M

Also see: PETX Shares Outstanding History
and PETX YTD Return
PETX Historical Market Cap:
+1.86% CAGR
PETX Historical Market Cap: +1.86% CAGR

Mouse over chart for data details
8/8/2013 ...5/3/2019
Aratana Therapeutics is a pet therapeutics company that licenses, develops and commercializes therapeutics for dogs and cats. At Dec 31 2017, Co.'s portfolio included multiple therapeutics and therapeutic candidates in development consisting of small molecule pharmaceuticals and molecule biologics. Co. has three U.S. Food and Drug Administration approved therapeutics: GALLIPRANT® (grapiprant tablets) for the control of pain and inflammation associated with osteoarthritis in dogs; ENTYCE® (capromorelin oral solution) for appetite stimulation in dogs; and NOCITA® (bupivacaine liposome injectable suspension) as a local post-operative analgesia for cranial cruciate ligament surgery in dogs. We show 24 historical shares outstanding datapoints in our PETX shares outstanding history coverage, used to compute PETX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PETX market cap history over the course of time is important for investors interested in comparing PETX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PETX versus a peer is one thing; comparing PETX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PETX can fluctuate over the course of history. With this page we aim to empower investors researching PETX by allowing them to research the PETX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PETX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aratana Therapeutics (PETX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PFE Market Cap History
PGEN Market Cap History
PGNX Market Cap History
PGNY Market Cap History
PHAS Market Cap History
PHAT Market Cap History
PHIO Market Cap History
PIII Market Cap History
PIRS Market Cap History
PKI Market Cap History
More Healthcare companies »

 

PETX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.